US Patent 11648235 Treatment of glioblastoma
Patent 11648235 was granted and assigned to Cantex Pharmaceuticals on May, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 30, 2022
0
Date of Patent
May 16, 2023
0
Patent Applicant
Patent Application Number
18148922
0
Patent Inventor Names
Stephen G. Marcus
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11648235 Treatment of glioblastoma
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.